Osteosarcoma Metastatic: Clinical Trials

1 trial for Osteosarcoma Metastatic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Recruiting 1

Follow Osteosarcoma Metastatic: new trials by email Literature Review of Osteosarcoma Metastatic trials Research Report on Osteosarcoma Metastatic

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse
Experimental group : Cabometyx ® 40mg/m2/day (Max: 60mg/day) , Treatment schedule : Daily**, day 1-28 during 4 weeks (ie. 1 cycle) during 12 cycles - Osteosarcoma, Pediatric Osteosarcoma
Phase 3RecruitingGustave Roussy, Cancer Campus, Grand Paris5302026-10-072026-10-26

Narrower conditions

Osteosarcoma (1)

Broader conditions

Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Bone Tissue (1)  ·  Neoplasms, Connective Tissue (1)  ·  Neoplasms, Connective and Soft Tissue (1)  ·  Sarcoma (1)

Interventions

MAX protein, human (1)

Sponsors

Gustave Roussy, Cancer Campus, Grand Paris (1)

Countries

Denmark (1)  ·  Finland (1)  ·  France (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Spain (1)  ·  Sweden (1)

NIH funding

2023 (1)